• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

老年急性下肢深静脉血栓形成患者腔内综合治疗的研究

Clinical study of comprehensive endovascular treatment for acute deep vein thrombosis in elderly patients

摘要目的 探讨老年急性下肢深静脉血栓形成(DVT)患者采用腔内综合治疗的安全性和临床疗效. 方法 回顾性分析2013年06月至2016年06月间我科采用腔内治疗的94例老年DVT患者的临床资料.患者均行下腔静脉滤器置入术(IVCF),57例采用血栓减容后辅助导管溶栓(CDT)治疗(血栓减容+CDT组),37例CDT治疗(CDT组).观察老年DVT患者各种治疗方法的有效性和安全性. 结果 94例患者可回收IVCF 88例,取出率为94.3%(83/88).血栓减容+CDT组和CDT组患者溶栓持续时间分别为(73.9±31.7)h和(156.2±30.2)h,灌注溶栓药物总量(180.71±44.83)万单位和(355.0±96.0)万单位(均P<0.05);平均住院时间(9.4±2.4)d和(12.8±4.3)d(t=-4.99,P<0.01);出院时两组疗效比较差异无统计学意义(x2=1.263,P>0.05);56例患者行血管成形术(PTA),其中34例同时联合置人支架,两组比较差异无统计学意义(x2=1.128,P>0.05);未发生严重并发症,小出血发生率为9.6%(9/94),血栓减容+CDT组和CDT组分别2例和7例(x2 =4.503,P=0.034).94例患者平均随访时间(16.7±8.3)个月,髂静脉支架通畅率为91.2%(31/34),末次随访多普勒超声结果显示瓣膜反流率为20.2%(19/94),血栓减容+CDT组和CDT组血栓后综合征发生率比较,差异无统计学意义(x2 =0.307,P=0.580).血栓减容+CDT组和CDT组患者Villata评分轻、中和重度分别为9例比6例、4例比5例、0例比1例(均P>0.05).结论 及时合理选择治疗策略,综合运用IVCF置人术、抗凝、腔内CDT、血栓减容、PTA术和腔内支架置入术等手段,对老年DVT患者安全、有效.

更多

abstractsObjective To investigate the safety and clinical efficacy of comprehensive endovascular treatment for acute deep vein thrombosis(DVT)in elderly patients.Methods Clinical data of 94 elderly patients who underwent endovascular treatment from June 2013 to June 2016 were retrospectively analyzed.All patients underwent inferior vena cava filter implantation (IVCF).Of them,57 patients initially underwent thrombectomy and subsequently received the adjunctive catheterdirected thrombolysis(CDT)(Group A)and 37 cases underwent CDT(Group B).Clinical efficacy and safety of treatments in the two groups were examined.Results Among the 94 patients,88 cases had retrievable IVCF,and the retrieval rate was 94.3% (83/88).There were significant differences in total infusion time(73.92 ± 31.68 h vs.156.2 ± 30.2 h) and total doses of infused thrombolytic agents (180.71± 44.83 million unit vs.355.0±96.0 million unit)between Groups A and B(P <0.05).There was a significant difference in average hospitalized time between Groups A and B(9.4±2.4 d vs.12.8 ± 4.3 d,t =-4.99,P <0.01).There was no significant difference in clinical efficacy between Groups A and B(x2 =1.263,P > 0.05).Fifty-six patients were treated with angioplasty(PTA),34 of them were combined with stent implantation,and there was no difference between the two groups(x2=1.128,P >0.05).Neither of the two groups saw serious complications.The incidence of minor hemorrhage was 9.6% (9/94),including 2 cases and 7 cases in Group A and Group B respectively,and the difference was statistically significant (x2 =4.503,P =0.034).The average follow-up time was 16.7± 8.3 months in the 94 patients,and the stent patency rate was 91.2% (31/34).Doppler ultrasonography results at the last follow-up showed that the reverse flow rate of the valve was 20.2% (19/94),the occurrence rates of post-thrombotic syndrome(PTS)were 24.6% (14/57)and 29.7%(11/37) in Group A and Group B respectively,and the difference was not statistically significant(x2=0.307,P =0.580).Patients in the mild,moderate and severe stages assessed by Villata scoring were 9 vs.6,4 vs.5,0 vs.1 in Group A and Group B respectively,and the differences were not statistically significant(x2 =0.007 and 0.205,P>0.05).Conclusions It is safe and effective for elderly patients with DVT when timely and appropriate the treatment strategies are chosen and comprehensive approaches including IVCF,anticoagulation,endovascular CDT,thrombectomy,PTA and stent implantation are used.

More
广告
栏目名称 临床研究
DOI 10.3760/cma.j.issn.0254-9026.2019.10.019
发布时间 2019-12-13
基金项目
江苏省临床医学科技专项资金 南京市医学科技发展重点项目 南京市医学科技发展项目(YKK14087)Clinical Medicine Science and Technology Projects of Jiangsu Province Medical,Science and Technology Developing Key Project of Nanjing of China Medical,Science and Technology Developing Project of Nanjing of China
  • 浏览226
  • 下载172
中华老年医学杂志

中华老年医学杂志

2019年38卷10期

1137-1141页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷